Regeneron’s experimental therapy combo effective in untreated cancer patients

Dec 6 (Reuters) – Regeneron (REGN.O), opens new tab said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients with a type of blood cancer in the first part…